Fundraising September 15, 2024 – October 1, 2024 About fundraising
1

The Androgen Receptor in Breast Cancer: Biology and Treatment Considerations

Year:
2012
Language:
english
File:
PDF, 196 KB
english, 2012
2

The role of the androgen receptor in triple-negative breast cancer

Year:
2013
Language:
english
File:
PDF, 557 KB
english, 2013
21

Bevacizumab for Advanced Breast Cancer

Year:
2007
Language:
english
File:
PDF, 293 KB
english, 2007
24

Advances in the Management of Triple Negative Breast Cancer ||

Year:
2011
Language:
english
File:
PDF, 3.83 MB
english, 2011
25

Triple-Negative Breast Cancer: Adjuvant Therapeutic Options

Year:
2011
Language:
english
File:
PDF, 172 KB
english, 2011
27

Bevacizumab for advanced breast cancer

Year:
2010
Language:
english
File:
PDF, 286 KB
english, 2010
28

IN18 TRIPLE NEGATIVE BREAST CANCER: THE ROLE OF ANDROGEN RECEPTOR AND ITS INHIBITORS

Year:
2015
Language:
english
File:
PDF, 69 KB
english, 2015
31

Triple-Negative Breast Cancer

Year:
2010
Language:
english
File:
PDF, 1.16 MB
english, 2010
32

Targeting the androgen receptor in triple negative breast cancer

Year:
2016
Language:
english
File:
PDF, 567 KB
english, 2016
35

Androgen receptor-positive, triple-negative breast cancer

Year:
2017
Language:
english
File:
PDF, 217 KB
english, 2017
36

The Androgen Receptor: Is It a Promising Target?

Year:
2017
Language:
english
File:
PDF, 394 KB
english, 2017
37

Androgen Receptor-Targeted Therapy for Breast Cancer

Year:
2017
Language:
english
File:
PDF, 421 KB
english, 2017
42

Reply to K.S. Shohdy et al

Year:
2018
Language:
english
File:
PDF, 434 KB
english, 2018